- Home
- FUTU vs DGX Comparison
FUTU vs DGX Comparison
Compare FUTU & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUTU | DGX |
|---|---|---|
| Founded | 2011 | 1967 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 20.5B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FUTU | DGX |
|---|---|---|
| Price | $180.22 | $179.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $208.60 | $196.69 |
| AVG Volume (30 Days) | ★ 982.5K | 871.4K |
| Earning Date | 11-18-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 119.17 | 14.49 |
| EPS | ★ 8.95 | 8.51 |
| Revenue | $2,442,834,991.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $85.62 | $12.37 |
| Revenue Next Year | $14.24 | $3.52 |
| P/E Ratio | ★ $20.24 | $20.38 |
| Revenue Growth | ★ 87.15 | 13.74 |
| 52 Week Low | $70.60 | $148.70 |
| 52 Week High | $202.53 | $197.55 |
Technical Indicators
Market Signals| Indicator | FUTU | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 53.09 |
| Support Level | $164.20 | $171.18 |
| Resistance Level | $168.22 | $176.37 |
| Average True Range (ATR) | 4.68 | 2.76 |
| MACD | 2.05 | 0.12 |
| Stochastic Oscillator | 72.53 | 63.81 |
Price Performance
Historical ComparisonAbout FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.